No Detail Found!

Applicability of the new espghan guidelines for diagnosing coeliac disease in children from resource limited countries.

Author(s)
Siba Prosad Paul Department of Paediatric Gastroenterology, Bristol Royal Hospital for Children, Paul O`Gorman Building, Upper Maudlin Street, Bristol BS2 8BJ, UK
Huma Mazhar Department of Paediatric Gastroenterology, Bristol Royal Hospital for Children, Paul O`Gorman Building, Upper Maudlin Street, Bristol BS2 8BJ, UK
Christine Helen Spray Department of Paediatric Gastroenterology, Bristol Royal Hospital for Children, Paul O`Gorman Building, Upper Maudlin Street, Bristol BS2 8BJ, UK
Abstract
Coeliac Disease (CD) is an immune-mediated systemic disorder elicited by the ingestion of gluten. Small-bowel biopsies and histology has been the gold standard for diagnosing CD. The modified ESPGHAN guidelines recommend that in symptomatic children with anti-tissue-Transglutaminase (tTG) titre of > 10 times Upper-Limit-of-Normal (ULN), diagnosis of CD can be made without small-bowel biopsies. However, positive HLA-DQ2/DQ8 serotype and anti-Endomysial Antibodies (EMA) are necessary. Studies from resource-limited countries have demonstrated applicability of the ESPGHAN guidelines for serological diagnosis of CD. CD should not be diagnosed on the basis of a single high tTG-titre. Small-bowel biopsies are necessary for diagnosing CD in asymptomatic children and those with tTG-titre
Publication Details
Page(s) 455-457
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 25, Issue: 6, Year: 2015

Request the full text from PASTIC

0

Citations

0

Downloads

89

Views